|
|
Balasubramanian Krishnamurthy, Nadine L. Dudek, Mark D. McKenzie, Anthony W. Purcell, Andrew G. Brooks, Shane Gellert, Peter G. Colman, Leonard C. Harrison, Andrew M. Lew, Helen E. Thomas, Thomas W.H. Kay
J Clin Invest. 2006;
116(12):3258
doi:10.1172/JCI29602
Abstract |
Full text
| PDF
| Supplemental material

T
ype 1 diabetes (T1D) is characterized by immune responses against several autoantigens expressed in pancreatic β cells. T cells specific for proinsulin and islet-specific glucose-6-phosphatase catalytic subunit–related protein (IGRP) can induce T1D in NOD mice. However, whether immune responses to multiple autoantigens are caused by spreading from one to another or whether they develop independently of each other is unknown. As cytotoxic T cells specific for IGRP were not detected in transgenic NOD mice tolerant to proinsulin, we determined that immune responses against proinsulin are necessary for IGRP-specific T cells to develop. On the other hand, transgenic overexpression of IGRP resulted in loss of intra-islet IGRP-specific T cells but did not protect NOD mice from insulitis or T1D, providing direct evidence that the response against IGRP is downstream of the response to proinsulin. Our results suggest that pathogenic proinsulin-specific immunity in NOD mice subsequently spreads to other antigens such as IGRP.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(44)
| Title and authors |
Publication |
Year |
Autoreactive Cytotoxic T Lymphocytes Acquire Higher Expression of Cytotoxic Effector Markers in the Islets of NOD Mice after Priming in Pancreatic Lymph Nodes
Kate L. Graham, Balasubramanian Krishnamurthy, Stacey Fynch, Zia U. Mollah, Robyn Slattery, Pere Santamaria, Thomas W. Kay, Helen E. Thomas
|
The American Journal of Pathology
|
2011 |
Antigen-Based Immune Therapeutics for Type 1 Diabetes: Magic Bullets or Ordinary Blanks?
Slobodan Culina, Christian Boitard, Roberto Mallone
|
Clinical and Developmental Immunology
|
2011 |
The pro-apoptotic BH3-only protein Bid is dispensable for development of insulitis and diabetes in the non-obese diabetic mouse
Zia U. A. Mollah, Jibran Wali, Mark D. McKenzie, Balasubramanian Krishnamurthy, Kate L. Graham, Stacey Fynch, Joshua Szanyi, Pere Santamaria, Thomas Brodnicki, Janette Allison, Andreas Strasser, Thomas W. H. Kay, Helen E. Thomas
|
Apoptosis
|
2011 |
Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope
C. Daniel, B. Weigmann, R. Bronson, H. von Boehmer
|
Journal of Experimental Medicine
|
2011 |
Multiple antigens versus single major antigen in type 1 diabetes: arguing for multiple antigens
Teresa P. DiLorenzo
|
Diabetes Metab. Res. Rev.
|
2011 |
Immunology of Diabetes Society T-Cell Workshop: HLA class II tetramer-directed epitope validation initiative
E. A. James, R. Mallone, N. C. Schloot, M. C. Gagnerault, J. Thorpe, L. Fitzgerald-Miller, J. Reichow, R. Wagner, M. N. Pham, N. Jospe
|
Diabetes Metab. Res. Rev.
|
2011 |
Insulin as a key autoantigen in the development of type 1 diabetes
Maki Nakayama
|
Diabetes Metab. Res. Rev.
|
2011 |
Molecular Targeting of Islet Autoantigens
Brian Stadinski, John Kappler, George S. Eisenbarth
|
Immunity
|
2010 |
An update on the use of NOD mice to study autoimmune (Type 1) diabetes
Rodolfo José Chaparro, Teresa P DiLorenzo
|
Expert Rev Clin Immunol
|
2010 |
Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease
John P. Driver, David V. Serreze, Yi-Guang Chen
|
Semin Immunopathol
|
2010 |
|